Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Lacombe

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 6, 2008
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)Jerzy Hildebrand, Thierry Gorlia, Johan M Kros, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastomaAlba A Brandes, Roger Stupp, Peter Hau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2026
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal groupHannah C Puhr, Fabio Cardoso Borges, Laure Monard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2018
Prospective data registration and clinical trials for particle therapy in EuropeJohannes A Langendijk, Roberto Orecchia, Karin Haustermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facilityAlysa Fairchild, Edwin Aird, Paul A Fenton, et al.
Nature Reviews. Drug Discovery|November 25, 2017
Steps forward for cancer precision medicineRoberto Salgado, Helen Moore, John W M Martens, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2017
Societal challenges of precision medicine: Bringing order to chaosRoberto Salgado, Helen Moore, John W M Martens, et al.
Japanese Journal of Clinical Oncology|November 6, 2018
Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigatorsKozo Kataoka, Orit Kaider-Person, Bernd Kasper, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2012
EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaYassine Lalami, Pol M Specenier, Ahmad Awada, et al.
Cancer Discovery|November 4, 2015
All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and HealthMark Lawler, Lillian L Siu, Heidi L Rehm, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|February 6, 2008
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)Jerzy Hildebrand, Thierry Gorlia, Johan M Kros, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastomaAlba A Brandes, Roger Stupp, Peter Hau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2026
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal groupHannah C Puhr, Fabio Cardoso Borges, Laure Monard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2018
Prospective data registration and clinical trials for particle therapy in EuropeJohannes A Langendijk, Roberto Orecchia, Karin Haustermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facilityAlysa Fairchild, Edwin Aird, Paul A Fenton, et al.
Nature Reviews. Drug Discovery|November 25, 2017
Steps forward for cancer precision medicineRoberto Salgado, Helen Moore, John W M Martens, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2017
Societal challenges of precision medicine: Bringing order to chaosRoberto Salgado, Helen Moore, John W M Martens, et al.
Japanese Journal of Clinical Oncology|November 6, 2018
Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigatorsKozo Kataoka, Orit Kaider-Person, Bernd Kasper, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2012
EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaYassine Lalami, Pol M Specenier, Ahmad Awada, et al.
Cancer Discovery|November 4, 2015
All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and HealthMark Lawler, Lillian L Siu, Heidi L Rehm, et al.
Pageof 12